Saba Sile

1.6k total citations
19 papers, 557 citations indexed

About

Saba Sile is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Ophthalmology. According to data from OpenAlex, Saba Sile has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 5 papers in Ophthalmology. Recurrent topics in Saba Sile's work include Ophthalmology and Eye Disorders (6 papers), Ion Transport and Channel Regulation (5 papers) and Glaucoma and retinal disorders (4 papers). Saba Sile is often cited by papers focused on Ophthalmology and Eye Disorders (6 papers), Ion Transport and Channel Regulation (5 papers) and Glaucoma and retinal disorders (4 papers). Saba Sile collaborates with scholars based in United States, Germany and Canada. Saba Sile's co-authors include Robert J. Holt, Chang Yu, George J. Kahaly, Terry J. Smith, Raymond S. Douglas, James V. Gainer, Nancy J. Brown, Albert Adam, John Nadeau and James Brian Byrd and has published in prestigious journals such as The Lancet, Blood and Hypertension.

In The Last Decade

Saba Sile

19 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saba Sile United States 11 158 145 120 89 86 19 557
Stefano Di Giulio Italy 10 133 0.8× 46 0.3× 55 0.5× 63 0.7× 42 0.5× 20 487
Satoshi Yoshiji Japan 8 248 1.6× 68 0.5× 92 0.8× 34 0.4× 41 0.5× 34 604
Sandro Feriozzi Italy 20 202 1.3× 262 1.8× 19 0.2× 33 0.4× 65 0.8× 73 1.3k
Esmeralda Castelblanco Spain 19 314 2.0× 72 0.5× 420 3.5× 16 0.2× 144 1.7× 70 1.1k
Denise D’Andrea United States 14 138 0.9× 59 0.4× 309 2.6× 45 0.5× 166 1.9× 29 862
Maria B. Grant United States 12 159 1.0× 14 0.1× 207 1.7× 105 1.2× 45 0.5× 22 580
Baoli Liu China 12 152 1.0× 84 0.6× 33 0.3× 23 0.3× 16 0.2× 34 572
Kumiko Torisu Japan 14 302 1.9× 49 0.3× 53 0.4× 23 0.3× 102 1.2× 44 837
Tao Jin China 10 212 1.3× 42 0.3× 87 0.7× 72 0.8× 103 1.2× 26 595
G Sansone Italy 15 193 1.2× 25 0.2× 49 0.4× 267 3.0× 93 1.1× 78 874

Countries citing papers authored by Saba Sile

Since Specialization
Citations

This map shows the geographic impact of Saba Sile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saba Sile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saba Sile more than expected).

Fields of papers citing papers by Saba Sile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saba Sile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saba Sile. The network helps show where Saba Sile may publish in the future.

Co-authorship network of co-authors of Saba Sile

This figure shows the co-authorship network connecting the top 25 collaborators of Saba Sile. A scholar is included among the top collaborators of Saba Sile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saba Sile. Saba Sile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Smith, Terry J., Rajib Bhattacharya, Kate Hsu, et al.. (2022). PSAT265 Blood Glucose in Thyroid Eye Disease (TED) in Patients treated with Teprotumumab: Clinical Trials Data. Journal of the Endocrine Society. 6(Supplement_1). A809–A809. 2 indexed citations
2.
Douglas, Raymond S., Yao Wang, Saba Sile, et al.. (2021). Teprotumumab use in a real-world setting: Expanded access program findings. Investigative Ophthalmology & Visual Science. 62(8). 3345–3345. 2 indexed citations
3.
Yan, Xin, Fengyan Xu, Yuying Gao, et al.. (2021). Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease. Clinical Pharmacokinetics. 60(8). 1029–1040. 18 indexed citations
5.
Kahaly, George J., Raymond S. Douglas, Robert J. Holt, Saba Sile, & Terry J. Smith. (2021). Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials. The Lancet Diabetes & Endocrinology. 9(6). 360–372. 109 indexed citations
6.
Kahaly, George J., Terry J. Smith, Robert A. Holt, Saba Sile, & Raymond S. Douglas. (2020). OR18-01 Effect of Teprotumumab on Proptosis Reduction Across Various Demographic Sub-Groups. Journal of the Endocrine Society. 4(Supplement_1). 2 indexed citations
7.
9.
Sile, Saba, Digna R. Velez, Jason H. Moore, et al.. (2009). CLCNKB-T481S and essential hypertension in a Ghanaian population. Journal of Hypertension. 27(2). 298–304. 29 indexed citations
10.
Grouzmann, Eric, et al.. (2008). Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema. Commentary. Hypertension. 51(1). 1 indexed citations
11.
Yu, Chang, Sanguo Zhang, Chuan Zhou, & Saba Sile. (2008). A likelihood ratio test of population Hardy‐Weinberg equilibrium for case‐control studies. Genetic Epidemiology. 33(3). 275–280. 29 indexed citations
12.
Hsu, Lewis L., Kenneth I. Ataga, Victor R. Gordeuk, et al.. (2008). Tetrahydrobiopterin (6R-BH4): Novel Therapy for Endothelial Dysfunction in Sickle Cell Disease. Blood. 112(11). lba–5. 5 indexed citations
13.
Byrd, James Brian, Saba Sile, James V. Gainer, et al.. (2007). Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema. Hypertension. 51(1). 141–147. 114 indexed citations
14.
Sile, Saba, et al.. (2007). Haplotype Diversity in Four Genes <i>(CLCNKA, CLCNKB, BSND, NEDD4L) </i>Involved in Renal Salt Reabsorption. Human Heredity. 65(1). 33–46. 13 indexed citations
15.
Sile, Saba, Digna R. Velez, Carlos G. Vanoye, et al.. (2007). Functional <italic>BSND</italic> Variants in Essential Hypertension<xref ref-type="author-notes" rid="fn1"><sup>*</sup></xref><subtitle />. American Journal of Hypertension. 20(11). 1176–1182. 11 indexed citations
16.
Sile, Saba, Carlos G. Vanoye, & Alfred L. George. (2006). Molecular physiology of renal ClC chloride channels/transporters. Current Opinion in Nephrology & Hypertension. 15(5). 511–516. 13 indexed citations
17.
Darbar, Dawood, Saba Sile, Frank A. Fish, & Alfred L. George. (2005). Congenital long QT syndrome aggravated by salt-wasting nephropathy. Heart Rhythm. 2(3). 304–306. 5 indexed citations
18.
Sile, Saba & Barry M. Wall. (2001). Acute renal failure secondary to spontaneous acute tumor lysis syndrome in myelofibrosis. American Journal of Kidney Diseases. 38(4). e21.1–e21.4. 16 indexed citations
19.
Muluk, Satish C., Lisa Painter, Saba Sile, et al.. (1997). Utility of clinical pathway and prospective case management to achieve cost and hospital stay reduction for aortic aneurysm surgery at a tertiary care hospital. Journal of Vascular Surgery. 25(1). 84–93. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026